Aim: The preparation of a delivery system able to guarantee a delayed release of lovastatin from red yeast rice (RYR) is mandatory to counteract cholesterol biosynthesis effectively. Materials & methods: Polymeric formulations were prepared mixing alginate and gelatin, in different ratios, with RYR. The effect of different composition on stiffness, viscosity, swelling behavior and mesostructure of matrices was analyzed. Results: Formulations obtained combining polymers in comparable amount (i.e., 60/40 and 50/50) guaranteed a delayed release of lovastatin from RYR, a prolonged inhibitory activity toward 3-hydroxy-3-methylglutaryl-coenzyme A reductase and a decreased cholesterol synthesis. Conclusion: The formulation obtained combining 60% gelatin and 40% of alginate showed physicochemical properties suitable to lead a lovastatin release profile compatible with cholesterol biosynthesis.
Leone, G., Consumi, M., Pepi, S., Lamponi, S., Bonechi, C., Tamasi, G., et al. (2017). Alginate-gelatin formulation to modify lovastatin release profile from red yeast rice for hypercholesterolemia therapy. THERAPEUTIC DELIVERY, 8(10), 843-854 [10.4155/tde-2017-0025].
Alginate-gelatin formulation to modify lovastatin release profile from red yeast rice for hypercholesterolemia therapy
LEONE, GEMMA;CONSUMI, MARCO;PEPI, SIMONE;LAMPONI, STEFANIA;BONECHI, CLAUDIA;TAMASI, GABRIELLA;DONATI, ALESSANDRO;ROSSI, CLAUDIO;MAGNANI, AGNESE
2017-01-01
Abstract
Aim: The preparation of a delivery system able to guarantee a delayed release of lovastatin from red yeast rice (RYR) is mandatory to counteract cholesterol biosynthesis effectively. Materials & methods: Polymeric formulations were prepared mixing alginate and gelatin, in different ratios, with RYR. The effect of different composition on stiffness, viscosity, swelling behavior and mesostructure of matrices was analyzed. Results: Formulations obtained combining polymers in comparable amount (i.e., 60/40 and 50/50) guaranteed a delayed release of lovastatin from RYR, a prolonged inhibitory activity toward 3-hydroxy-3-methylglutaryl-coenzyme A reductase and a decreased cholesterol synthesis. Conclusion: The formulation obtained combining 60% gelatin and 40% of alginate showed physicochemical properties suitable to lead a lovastatin release profile compatible with cholesterol biosynthesis.File | Dimensione | Formato | |
---|---|---|---|
RYR_TD.pdf
non disponibili
Tipologia:
PDF editoriale
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
360.97 kB
Formato
Adobe PDF
|
360.97 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
https://hdl.handle.net/11365/1019156